drugset / Trial / NCT01517009
A Multicenter Phase II Study of Neoadjuvant Docetaxel, Cisplatin and Capecitabine and Protocolized Surgery in Resectable Gastric Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the feasibility of chemotherapy, consisting of docetaxel, cisplatin and capecitabine given prior to surgery for stomach cancer. Furthermore, an extended type of removal of lymph nodes will be implemented.
Timeline
- Start
- 2008-06
- Primary completion
- 2012-11
- Completion
- 2013-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | 1875 mg/m2 | — |
| Subject | Cisplatin | Other / unclassified | 60 mg/m2 | — |
| Subject | Docetaxel | Small molecule | 60 mg/m2 | — |